Recruitment completed for PrimECC study
PrimECC® is a CE-marked and patent-protected product, developed to prime the heart-lung machine before open heart surgery. A previous “proof of concept” study performed using PrimECC® has shown interesting clinical results. Recruitment is now complete for a study including a total of 80 patients that aims to increase the clinical documentation for PrimECC®. Analysis of the results will now begin and it is estimated that the first publication from the study will be towards the end of 2017.Several hundred thousand heart operations are performed in the world each year using a heart-lung